Chemical structure verification is a tedious but critical task in the drug discovery and development pipeline. Despite the advances in automation, AI and high-throughput screening that have ...
With tightening budgets and increasing pressure to de-risk R&D, pharma and biotech are shifting their focus toward smarter, more efficient drug design. Companies are investing more in enabling ...
JERUSALEM, April 6, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI); ("Scinai" or the "Company"), a biopharmaceutical company developing inflammation and immunology therapeutics and ...
Have you heard the boom created by Cryo-EM? Drug development has been shaken up with the application of Cryo-EM, accelerating and increasing the rate of success of protein targeting by identifying new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results